Kala Pharmaceuticals
$6.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.11 (-1.80%) As of 1:56 PM EST today
-$0.11 (-1.80%) Today
Why Robinhood?
You can buy or sell KALA and other stocks, options, ETFs, and crypto commission-free!
About KALA
Kala Pharmaceuticals, Inc. Common Stock, also called Kala Pharmaceuticals, is a biopharmaceutical company. Read More It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.
Employees
136
Headquarters
Watertown, Massachusetts
Founded
2009
Market Cap
239.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
768.63K
High Today
$6.15
Low Today
$5.95
Open Price
$6.12
Volume
444.04K
52 Week High
$8.98
52 Week Low
$3.24
Collections
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
KALA Earnings
-$0.76
-$0.51
-$0.25
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.60 per share
Actual
-$0.63 per share
People Also Bought
Viking Therapeutics
39,709
$6.29
-1.26%Verastem
17,641
$1.99
+0.76%Nabriva Therapeutics
3,244
$1.39
-1.42%NIO
130,296
$4.38
-0.38%Nektar Therapeutics
4,920
$21.32
-3.75%Teva Pharmaceutical
21,255
$12.91
-2.53%Inovio
61,709
$3.86
+3.38%Geron
31,481
$1.16
+0.43%CannTrust
103,209
$0.7486
-1.87%Pareteum
29,379
$0.5788
-1.51%Abeona Therapeutics
2,238
$3.66
-5.91%TherapeuticsMD
13,670